FMP
scPharmaceuticals Inc.
SCPH
NASDAQ
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts.
3.38 USD
-0.04 (-1.18%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
ceo
Mr. John H. Tucker
sector
Healthcare
industry
Biotechnology
exchange
NASDAQ
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. sc...
CIK
0001604950
ISIN
US8106481059
CUSIP
810648105
Address
2400 District Avenue
Phone
617 517 0730
Country
US
Employee
135
IPO Date
Nov 17, 2017
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
SCPH Financial Summary
CIK
0001604950
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
810648105
ISIN
US8106481059
Country
US
Price
3.38
Beta
0.14
Volume Avg.
438.81k
Market Cap
169.14M
Shares
-
52-Week
3.075-6.6
DCF
3.05
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-1.73
P/B
-
Website
https://www.scpharmaceuticals.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest SCPH News
It looks like there's no news available.
